04/03/2024 4:30 PM | Bashan Dror (Reporting) Protalix BioTherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 6:03 AM | Protalix BioTherapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/14/2024 5:57 AM | Protalix BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/02/2024 5:36 AM | NACHT MARIUS (Filed by) Protalix BioTherapeutics (Subject)
| Form SC 13G/A | |
12/26/2023 5:56 AM | Protalix BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 6:50 AM | Protalix BioTherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023 6:22 AM | Protalix BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
10/20/2023 5:50 AM | Bashan Dror (Reporting) Protalix BioTherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/15/2023 3:45 PM | Forster Eliot (Reporting) Protalix BioTherapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
09/15/2023 3:46 PM | Forster Eliot (Reporting) Protalix BioTherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2023 5:58 AM | Protalix BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/17/2023 3:30 PM | Naos Yaron (Reporting) Protalix BioTherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/17/2023 3:30 PM | Hayon Yael (Reporting) Protalix BioTherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/17/2023 3:30 PM | Protalix BioTherapeutics (Issuer) Rubin Eyal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/17/2023 3:30 PM | Bashan Dror (Reporting) Protalix BioTherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 6:02 AM | Protalix BioTherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/07/2023 5:59 AM | Protalix BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/13/2023 3:41 PM | Protalix BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/29/2023 6:24 AM | Protalix BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/28/2023 3:30 PM | Protalix BioTherapeutics (Filer)
| Form DEFA14A | |
05/30/2023 6:23 AM | Protalix BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/18/2023 5:57 AM | Protalix BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2023 5:25 AM | Protalix BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/05/2023 5:56 AM | Protalix BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/04/2023 3:30 PM | Protalix BioTherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023 6:37 AM | Protalix BioTherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/02/2023 7:26 AM | Protalix BioTherapeutics (Filer)
| Form PRE 14A | |
05/01/2023 5:47 AM | Protalix BioTherapeutics (Filer)
| Form 10-K/A | |